Key terms

About WBA

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest WBA news

Yesterday 5:10am ET Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Ocular Therapeutix (OCUL) and Elevance Health (ELV) Apr 15 7:20am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Walgreens Boots Alliance (WBA) and Evolent Health (EVH) Apr 12 12:33pm ET Walgreens Boots Alliance participates in a conference call with JPMorgan Apr 08 5:49am ET Buy Rating Affirmed for Walgreens Amid Strategic Financial Restructuring and Management Optimism Apr 03 3:31pm ET Walgreens disclosed $2.7B tax liability from IRS, says UBS Apr 03 9:16am ET Walgreens Boots Alliance price target lowered to $22 from $23 at Deutsche Bank Apr 03 7:28am ET Walgreens Boots Alliance price target lowered to $35 from $37 at TD Cowen Apr 02 6:26am ET Walgreens Stock (NASDAQ:WBA): Tax Concerns Overblown, Says Analyst Apr 01 7:21am ET Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA) Apr 01 3:40am ET Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Walgreens Boots Alliance (WBA) and Kodiak Sciences (KOD) Mar 31 4:09pm ET Walgreens Boots Alliance price target lowered to $20 from $21 at Morgan Stanley Mar 30 5:02am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Walgreens Boots Alliance (WBA), DiaSorin S.p.A. (GB:0GZX) and Novozymes (GB:0Q4U) Mar 28 6:27pm ET Walgreens Boots Alliance CEO: We’re focused on improving front end of the store Mar 28 5:13pm ET Walgreens Announces Executive Leadership Transition and Consultancy Mar 28 9:41am ET Unusually active option classes on open March 28th Mar 28 8:07am ET WBA Earnings: Walgreens Tanks on Narrowed Outlook Mar 28 8:05am ET Options Volatility and Implied Earnings Moves Today, March 28, 2024 Mar 28 7:32am ET Walgreens Boots Alliance Q1 Earnings Call and Insights Mar 28 7:12am ET Walgreens narrows FY24 adjusted EPS view to $3.20-$3.25 from $3.20-$3.50 Mar 28 7:05am ET Walgreens Boots Alliance reports Q2 adjusted EPS $1.20, consensus 82c Mar 27 8:25pm ET Notable companies reporting before tomorrow’s open Mar 27 1:20pm ET Notable companies reporting before tomorrow’s open Mar 26 6:30am ET Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), Elevance Health (ELV) and Stoke Therapeutics (STOK) Mar 26 6:26am ET Walgreens Boots Alliance Sell Rating: Declining Sales and Uncertain Future Direction Mar 25 3:46pm ET Walgreen Boots call volume above normal and directionally bullish Mar 25 8:00am ET Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024 Mar 22 10:46am ET Walgreen Boots call volume above normal and directionally bullish Mar 21 6:10am ET Analysts’ Top Healthcare Picks: Trevi Therapeutics (TRVI), Walgreens Boots Alliance (WBA) Mar 20 3:16am ET Barclays Remains a Sell on Walgreens Boots Alliance (WBA) Mar 18 8:22am ET Walgreens Boots Alliance price target lowered to $22 from $23 at Leerink Mar 15 9:40am ET Unusually active option classes on open March 15th

WBA Financials

1-year income & revenue

Key terms

WBA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

WBA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms